Skip to main content
Fig. 1 | BMC Research Notes

Fig. 1

From: Glycogen synthase kinase 3 (GSK-3) controls T-cell motility and interactions with antigen presenting cells

Fig. 1

GSK-3 inhibition decreases T-cell motility. Cells treated with GSK-3 inhibitors (Left panel: SB415286, Middle panel: SB216763, right panel: L803-mts) for 7 days show reduced motility in the presence of target cells (EL4-OVA). Tracking of 30 individual cells showed differences in a velocity, b displacement and c length of track travelled. Spider plots (d) show the traced tracks of all cells in area imaged. Data shown representative of three independent experiments. **** P value < 0.0001. Mean shown ± standard deviation

Back to article page
\